Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft. [electronic resource]
Producer: 19990622Description: 443-50 p. digitalISSN:- 0268-3369
- Adolescent
- Adult
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Bone Marrow Transplantation -- adverse effects
- CD4-Positive T-Lymphocytes -- immunology
- CD8-Positive T-Lymphocytes -- immunology
- Child
- Combined Modality Therapy
- Female
- Graft vs Host Disease -- etiology
- Hematologic Neoplasms -- immunology
- Histocompatibility Testing
- Humans
- Immunomagnetic Separation
- Immunosuppressive Agents -- administration & dosage
- Lymphocyte Depletion
- Male
- Methotrexate -- administration & dosage
- Middle Aged
- Transplantation, Homologous
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.